Assessment of clinical outcomes such as 30-day mortality following coronary revascularization procedures has historically been used to spur quality improvement programs. Public reporting of risk-adjusted outcomes is already mandated in several states, and proposals to further expand public reporting have been put forward as a means of increasing transparency and potentially incentivizing high quality care. However, for public reporting of outcomes to be considered a useful surrogate of procedural quality of care, several prerequisites must be met. First, the reporting measure must be truly representative of the quality of the procedure itself, rather than be dominated by other underlying factors, such as the overall level of illness of a patient. Second, to foster comparisons among physicians and institutions, the metric requires accurate ascertainment of and adjustment for differences in patient risk profiles. This is particularly relevant for high-risk clinical patient scenarios. Finally, the potential deleterious consequences of public reporting of a quality metric should be considered prior to expanding the use of public reporting more broadly. In this viewpoint, the authors review in particular the characterization of high-risk patients currently treated by percutaneous coronary interventional procedures, assessing the adequacy of clinical risk models used in this population. They then expand upon the limitations of 30-day mortality as a quality metric for percutaneous coronary intervention, addressing the strengths and limitations of this metric, as well as offering suggestions to enhance its future use in public reporting. (J Am Coll Cardiol Intv 2016;9: 2077-85)
C alls for public reporting of cardiovascular outcomes have been growing, with transparency touted as a fundamental component of quality improvement in an emerging era of valuebased health care (1) . Public reporting of outcomes following coronary revascularization procedures is already available in several states, with a number of proposals for its expansion looming (2, 3) . As an example, the American College of Cardiology has announced plans for voluntary public reporting of process-related institutional data for limited metrics as a first step toward public reporting within the National Cardiovascular Data Registry (4) . Increasingly, regulators are legislating public reporting, while payers may use these data to rank physicians (5).
These efforts stem from a desire for transparency in outcomes to both ensure and incentivize high-quality care and to guide patients in their selection of providers and hospitals.
However, fair comparisons among hospitals and physicians require accurate risk assessment and/or risk adjustment in the reporting process by accounting for case selection and case mix at the levels of both hospitals and physicians. In addition, it is imperative that data collection be accurate and that the reporting measure being publicly reported be truly representative of the quality of the procedure rather than be dominated by other underlying conditions of the patient. However, the use of RAMR as a surrogate comparative metric of PCI quality may be misleading, because mortality at 30 days following PCI is frequently not directly related to procedural quality itself (6) . Herein lies a fundamental dichotomy related to the use of this metric: although there can be utility in the identification of hospital and physician outliers through examination of 30-day mortality rates, lesser degrees of variability encompassed within comparisons of these rates may have little to do with actual differences in PCI quality, and when taken out of context, these perceived differences can be inappropriately magnified.
Risk adjustment may be one way to address the variability in patient and procedure selection.
Yet although the underlying risk of patients undergoing PCI bears a strong influence upon the subsequent occurrence of 30-day mortality, the methodology for risk adjustment varies across state and national registries, with no clear consensus favoring a particular risk adjustment model or strategy. Inadequate accounting of risk in RAMR assessments can inadvertently-when these data are either used as part of a quality improvement initiative or publicly reportedimpugn the quality of care offered by providers and hospitals. Particularly for higher risk patients, concerns about how public reporting of RAMR might affect the reputation of a physician and/or hospital can lead to "nonclinical" influences during case selection (such as risk aversion) (7) which may run contrary to the best interest of patients being assessed for treatment.
The conundrum of how to incentivize high-quality care while minimizing the untoward potential impact of public reporting upon the care of high-risk patients is of critical concern to the interventional cardiology community. In this viewpoint, we review in particular specific high-risk patient populations currently treated with PCI procedures, assessing the adequacy of risk models assessing mortality used in this population. We then expand upon the limitations of 30-day mortality as a quality metric for PCI, addressing the implications of public reporting of this metric. We finally offer potential solutions to address the limitations of this metric if used for public reporting, particularly in the context of preserving and enhancing the assessment of PCI-related quality.
HIGH-RISK PATIENT POPULATIONS
Several subgroups of patients have traditionally been considered to be at high risk for adverse outcomes following PCI. These include patients with cardiogenic shock or the resuscitated cardiac arrest patients with post-arrest anoxic encephalopathy. Additionally, patients indicated for complex revascularization but who are deemed nonsurgical-because of extremely high surgical risk, unfavorable anatomy, or other factors precluding surgical revascularizationrepresent a subset of "high-risk" patients for whom there is increasing interest in the potentially less morbid revascularization afforded by PCI. In these high-risk populations, the increased mortality risk is frequently due to elevated baseline mortality risk, not the actual quality or complexity of the percutaneous revascularization procedure (8) .
PCI IN PATIENTS FOLLOWING CARDIAC ARREST.
Observational studies suggest better outcomes when early coronary angiography and revascularization are performed for patients post-arrest (9) . In the INTCAR (International Cardiac Arrest Registry) registry of comatose post-cardiac patients, 80% of patients with ST-segment elevation myocardial infarction (STEMI) present on electrocardiography and 33% of patients without STEMI on electrocardiography had evidence of a culprit lesion (mostly total occlusions) on angiography; functional status among comatose patients even without evidence of STEMI was improved in those who underwent coronary angiography (10) .
Mortality rates for patients with out-of-hospital cardiac arrest remain high even in contemporary trials, approaching 50%, with two-thirds of these deaths a result of neurological causes and occurring irrespective of whether coronary angiography and PCI are performed (11) . When PCI is performed in these Gupta et al. Patients in cardiogenic shock represent another highrisk category. A landmark randomized trial demonstrated that shock patients are among those with the most to gain from invasive management and coronary revascularization, with 62% of hospital survivors assigned to early revascularization alive at 6 years, compared with only 44% of patients managed conservatively (13) . As a result of these data in addition to corroborative observational data, revascularization of patients with myocardial infarction complicated by shock is viewed as current standard of care, with a class I recommendation in current clinical guidelines (14) . Given the high mortality, however, shock patients can be disproportionally represented in an individual physician's and institution's count of mortalities occurring after PCI, which is why some states current exclude these patients in public reporting. different risk models applied to patients undergoing high-risk PCI with hemodynamic support, all assessed risk models were reasonably correlated but had poor discriminatory capacity for overall mortality (17) . Efforts have been made to add additional covariates to strengthen the performance of risk models (32) . In a recent analysis using data from the CathPCI Registry, RAMR was reported to be well calibrated among registry-defined high-risk patients, and those hospitals treating the largest number of such patients actually had better risk-adjusted outcomes than those treating patients with lower severity of illness (18) .
However, because high-risk patients in this internally validated study were necessarily defined by the variables collected in the dataset, such an analysis provides little assurance that unaccounted for markers of risk, such as frailty, will not distort comparisons in a manner that falsely impugns those providers and hospitals accepting the highest risk patients. Procedural registries not capturing these factors have no ability to assess the influence of their omission on public reporting metrics.
Finally, in a detailed observational registry study evaluating patients referred for elective PCI of an unprotected left main coronary artery, one-half of the patients were considered to be surgically "ineligible."
Among the patients who were deemed unsuitable for Gupta et al.
cardiac surgery, three-quarters had at least 1 risk factor not captured on the CathPCI Registry form that contributed to a high risk for CABG (16) . Notably, when compared with patients who underwent elective PCI of the left main coronary artery who were also "eligible" for CABG, these CABG-"ineligible" patients had a >6-fold increased risk for death at 1 year.
After adjusting for European System for Cardiac
Operative Risk Evaluation score, Society of Thoracic Surgeons score, or National Cardiovascular Data
Registry-based predicted mortality, the mere presence of surgical ineligibility remained an independent predictor of 1-year mortality. Thus the bedside evaluation of such patients was able to identify important prognostic clinical factors that greatly increased patient risk and were not accounted for using conventional risk adjustment methodology.
Because surgical "ineligibility," in most circumstances, involves evaluation by a cardiac surgeon, it could be expected that such high-risk patients would be concentrated at tertiary care referral centers with cardiac surgical programs, fulfilling the preconditions for introducing statistical bias into the public reporting measure.
The majority of current PCI registries do not collect specific data concerning patient frailty, patient preferences, or extenuating circumstances that may be highly relevant to the decisions being made for choice of revascularization. Physician's judgment that a patient is "nonsurgical" is an important prognostic factor that is independently associated with a high likelihood for a poor outcome; however, this remains a difficult variable to reliably and consistently record. This is especially important when considering the notion of "gaming the system" by the up-coding of variables defining high risk; independent evaluation by a cardiac surgeon may help mitigate this risk.
Overestimation of patient risk, termed "coding creep," was suggested as early as 1995 in the Cardiac Surgery Reporting System in New York in the setting of CABG, for which the incidence of high-risk variables increased >10-fold when reporting was analyzed (33) . Separately, an audit of high-risk variables in PCI found these factors overreported compared with independent adjudication (34) . In this analysis, there were consistent differences between reported data and audited data, especially in cases with shock or salvage PCI or emergent cases in which acuity was in fact reassigned by the auditing committee, ranging from 15% to 43% of cases.
When adjustment is applied to procedural-based registries, rather than disease-based registries, even the most accurate forms of procedural risk adjustment cannot take into account the clinical consequences of risk avoidance behaviors (or cases that never enter the procedural database because they are simply not performed). Despite the importance placed on risk-adjusted PCI mortality as a quality measure, it is not clear to what extent PCI mortality truly reflects the quality of the procedure.
Because the "optimal RAMR" for any given case mix is largely unknown, RAMR can be used to identify "outliers" above the 90th percentile of RAMR to screen for variability in overall interventional program quality. However, in a review of PCI mortality over an 8-year period at a single center, 3 physicians reviewing all PCI-related deaths found that 93% of all deaths were either mostly or entirely unpreventable, and only 7% of total deaths appeared to be directly related to the PCI procedure (6) . As a result, in cir- 
POSSIBLE REMEDIES RELATED TO CONCERNS ABOUT PUBLIC REPORTING
Because RAMR is sensitive only to the covariates specifically included in the derivation of the risk adjustment models used to calculate RAMR, it is important to recognize that behavior driven by inadequate risk assessment can have unintended consequences for patient care. One possible solution that is already being used in specific high-risk scenarios is to introduce further captured variables into the databases used for the risk modeling. This might involve specific modeling for identified high-risk patient features. For example, a series of data fields that can assess surgical eligibility as part of a heart teambased approach (requiring documentation of the specific reasons for considering a patient too high risk for surgery, for example in Table 1 ), could capture those reasons that rendered a patient ineligible for CABG, and these could be used in subsequent risk modeling. The most recent proposed update to the data collection form within the CathPCI Registry contains several elements specifically designed to implement this approach ( Table 2) . state-specific chapters of societies will be able to take on the charge to lead these processes is uncertain.
RECOMMENDATIONS
Devising solutions aimed at addressing objective outcomes assessment in high-risk patients is critically important in order to avoid scenarios in which patients are not being offered revascularization strategies that may substantially improve their quality of 
Gupta et al. Finally, although challenging, we believe that it will be important to move toward disease-based registries, in which patients who do not undergo procedures are also included, as a more accurate assessment of overall quality delivered for a particular condition and a check against risk-averse behavior that can harm patients. Another approach would be to deemphasize outcomes measures such as RAMR and instead report on more process-oriented measures, as has been already established through the CathPCI
Registry's reporting of discharge medication use.
In the interim, absent improved models of risk, only data on RAMR for usual-risk patients should be considered for public reporting; the outcomes reported for high-risk patients would not generally be relevant to the public's need when selecting providers and hospitals and therefore need not be available for the public to scrutinize. Either high-risk patients should be excluded from the metric used to report overall outcomes to the public, or registry agencies should institute a process to allow external peer review of all mortality cases prior to potential public reporting, excluding cases if the deaths that occur are clearly unrelated to the PCI procedure or hospital quality of care. Reporting system-based or hospital-based outcomes rather than individual scores for PCI performed for cardiac arrest, cardiogenic shock, and salvage patients such as patients declined by or considered high risk for cardiac surgery
Reporting of process-oriented rather than outcomes measures
Reporting of disease-based outcomes rather than procedure-based outcomes PCI ¼ percutaneous coronary intervention.
